世界のBRAFキナーゼ阻害剤産業調査2019-2025

• 英文タイトル：Global BRAF Kinase Inhibitors Industry Research Report, Growth Trends and Competitive Analysis 2019-2025

• レポートコード：QYR9NV15338
• 出版社/出版日：QYResearch / 2019年11月16日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、113ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医薬品・ヘルスケア

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

※本調査レポートでは、世界のBRAFキナーゼ阻害剤市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。BRAFキナーゼ阻害剤の種類別には、ダブラフェニブ、ソラフェニブ、ベムラフェニブ、エンコラフェニブに、用途別には、病院、医学研究所、クリニック、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査レポートの概要
・グローバル成長傾向・産業動向
・企業別市場シェア
・BRAFキナーゼ阻害剤の種類別市場規模：ダブラフェニブ、ソラフェニブ、ベムラフェニブ、エンコラフェニブ
・BRAFキナーゼ阻害剤の用途別市場規模：病院、医学研究所、クリニック、その他
・BRAFキナーゼ阻害剤の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ
・主要企業のプロフィール：Array BioPharma Inc.、Bayer AG、F. Hoffmann-La Roche Ltd.、Novartis AG
・市場規模予測2019-2025：生産量
・市場規模予測2019-2025：消費量
・バリューチェーン・販売チャネル分析
・市場機会・課題分析
...

BRAF kinase inhibitors are generally used as targeted therapy drugs for the treatment of carcinomas such as RCC, NSCLC, and melanomas caused by mutations of the BRAF gene.These drugs directly target BRAF protein and inhibit the growth of tumors in patients with metastatic melanoma. Such results delivered by the BRAF kinase inhibitors has encouraged several R&D teams to extend research on other applications. Moreover, many BRAF kinase inhibitor drugs are in the final stages of development and are expected to be launched during the forecast period.
In 2018, the global BRAF Kinase Inhibitors market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for BRAF Kinase Inhibitors.

This study researches the market size of BRAF Kinase Inhibitors, presents the global BRAF Kinase Inhibitors sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
This report focuses on the key data information of BRAF Kinase Inhibitors in key regions like North America, Europe, China and Japan, presents sales, revenue, market share, growth rate of BRAF Kinase Inhibitors for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2014 to 2019.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
Bayer AG
F. Hoffmann-La Roche Ltd.
Novartis AG
…

Market Segment by Product Type
Dabrafenib
Sorafenib
Vemurafenib
Encorafenib

Market Segment by Application
Hospital
Medical Research Institute
Clinic
Other

Market size split by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global BRAF Kinase Inhibitors status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key BRAF Kinase Inhibitors manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of BRAF Kinase Inhibitors are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

レポート目次

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global BRAF Kinase Inhibitors Market Size Growth Rate by Type
1.3.2 Dabrafenib
1.3.3 Sorafenib
1.3.4 Vemurafenib
1.3.5 Encorafenib
1.4 Market Segment by Application
1.4.1 Global BRAF Kinase Inhibitors Market Share by Application (2019-2025)
1.4.2 Hospital
1.4.3 Medical Research Institute
1.4.4 Clinic
1.4.5 Other
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global BRAF Kinase Inhibitors Market Size
2.1.1 Global BRAF Kinase Inhibitors Revenue 2014-2025
2.1.2 Global BRAF Kinase Inhibitors Sales 2014-2025
2.2 BRAF Kinase Inhibitors Growth Rate by Regions
2.2.1 Global BRAF Kinase Inhibitors Sales by Regions 2014-2019
2.2.2 Global BRAF Kinase Inhibitors Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 BRAF Kinase Inhibitors Sales by Manufacturers
3.1.1 BRAF Kinase Inhibitors Sales by Manufacturers 2014-2019
3.1.2 BRAF Kinase Inhibitors Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 BRAF Kinase Inhibitors Revenue by Manufacturers (2014-2019)
3.2.2 BRAF Kinase Inhibitors Revenue Share by Manufacturers (2014-2019)
3.2.3 Global BRAF Kinase Inhibitors Market Concentration Ratio (CR5 and HHI)
3.3 BRAF Kinase Inhibitors Price by Manufacturers
3.4 Key Manufacturers BRAF Kinase Inhibitors Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into BRAF Kinase Inhibitors Market
3.6 Key Manufacturers BRAF Kinase Inhibitors Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Dabrafenib Sales and Revenue (2014-2019)
4.1.2 Sorafenib Sales and Revenue (2014-2019)
4.1.3 Vemurafenib Sales and Revenue (2014-2019)
4.1.4 Encorafenib Sales and Revenue (2014-2019)
4.2 Global BRAF Kinase Inhibitors Sales Market Share by Type
4.3 Global BRAF Kinase Inhibitors Revenue Market Share by Type
4.4 BRAF Kinase Inhibitors Price by Type

5 Market Size by Application
5.1 Overview
5.1 Global BRAF Kinase Inhibitors Sales by Application

6 North America
6.1 North America BRAF Kinase Inhibitors Breakdown Data by Company
6.2 North America BRAF Kinase Inhibitors Breakdown Data by Type
6.3 North America BRAF Kinase Inhibitors Breakdown Data by Application
6.4 North America BRAF Kinase Inhibitors Breakdown Data by Countries
6.4.1 North America BRAF Kinase Inhibitors Sales by Countries
6.4.2 North America BRAF Kinase Inhibitors Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe BRAF Kinase Inhibitors Breakdown Data by Company
7.2 Europe BRAF Kinase Inhibitors Breakdown Data by Type
7.3 Europe BRAF Kinase Inhibitors Breakdown Data by Application
7.4 Europe BRAF Kinase Inhibitors Breakdown Data by Countries
7.4.1 Europe BRAF Kinase Inhibitors Sales by Countries
7.4.2 Europe BRAF Kinase Inhibitors Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific BRAF Kinase Inhibitors Breakdown Data by Company
8.2 Asia Pacific BRAF Kinase Inhibitors Breakdown Data by Type
8.3 Asia Pacific BRAF Kinase Inhibitors Breakdown Data by Application
8.4 Asia Pacific BRAF Kinase Inhibitors Breakdown Data by Regions
8.4.1 Asia Pacific BRAF Kinase Inhibitors Sales by Countries
8.4.2 Asia Pacific BRAF Kinase Inhibitors Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Thailand
8.4.10 Malaysia
8.4.11 Philippines
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America BRAF Kinase Inhibitors Breakdown Data by Company
9.2 Central & South America BRAF Kinase Inhibitors Breakdown Data by Type
9.3 Central & South America BRAF Kinase Inhibitors Breakdown Data by Application
9.4 Central & South America BRAF Kinase Inhibitors Breakdown Data by Countries
9.4.1 Central & South America BRAF Kinase Inhibitors Sales by Countries
9.4.2 Central & South America BRAF Kinase Inhibitors Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa BRAF Kinase Inhibitors Breakdown Data by Type
10.2 Middle East and Africa BRAF Kinase Inhibitors Breakdown Data by Application
10.3 Middle East and Africa BRAF Kinase Inhibitors Breakdown Data by Countries
10.3.1 Middle East and Africa BRAF Kinase Inhibitors Sales by Countries
10.3.2 Middle East and Africa BRAF Kinase Inhibitors Revenue by Countries
10.3.3 Turkey
10.3.4 GCC Countries
10.3.5 Egypt
10.3.6 South Africa

11 Company Profiles
11.1 Array BioPharma Inc.
11.1.1 Array BioPharma Inc. Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of BRAF Kinase Inhibitors
11.1.4 BRAF Kinase Inhibitors Product Introduction
11.1.5 Array BioPharma Inc. Recent Development
11.2 Bayer AG
11.2.1 Bayer AG Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of BRAF Kinase Inhibitors
11.2.4 BRAF Kinase Inhibitors Product Introduction
11.2.5 Bayer AG Recent Development
11.3 F. Hoffmann-La Roche Ltd.
11.3.1 F. Hoffmann-La Roche Ltd. Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of BRAF Kinase Inhibitors
11.3.4 BRAF Kinase Inhibitors Product Introduction
11.3.5 F. Hoffmann-La Roche Ltd. Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of BRAF Kinase Inhibitors
11.4.4 BRAF Kinase Inhibitors Product Introduction
11.4.5 Novartis AG Recent Development

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 BRAF Kinase Inhibitors Sales Channels
12.2.2 BRAF Kinase Inhibitors Distributors
12.3 BRAF Kinase Inhibitors Customers

13 Market Forecast
13.1 Global BRAF Kinase Inhibitors Sales and Revenue Forecast 2019-2025
13.2 Global BRAF Kinase Inhibitors Sales Forecast by Type
13.3 Global BRAF Kinase Inhibitors Sales Forecast by Application
13.4 BRAF Kinase Inhibitors Forecast by Regions
13.4.1 Global BRAF Kinase Inhibitors Sales Forecast by Regions 2019-2025
13.4.2 Global BRAF Kinase Inhibitors Revenue Forecast by Regions 2019-2025
13.5 North America Market Forecast
13.5.1 North America BRAF Kinase Inhibitors Forecast by Countries 2019-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe BRAF Kinase Inhibitors Forecast by Countries 2019-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific BRAF Kinase Inhibitors Sales Forecast by Regions 2019-2025
13.7.2 China
13.7.3 Japan
13.7.4 South Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America BRAF Kinase Inhibitors Sales Forecast by Countries 2019-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa BRAF Kinase Inhibitors Sales Forecast by Countries 2019-2025
13.9.2 Turkey
13.9.3 GCC Countries
13.9.4 Egypt
13.9.5 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure BRAF Kinase Inhibitors Product Picture
Table BRAF Kinase Inhibitors Key Market Segments
Table Major Manufacturers BRAF Kinase Inhibitors Covered in This Report
Table Global BRAF Kinase Inhibitors Market Size Growth Rate by Type 2019-2025 (K Liter) & (Million US$)
Figure Global BRAF Kinase Inhibitors Sales Market Shar by Type 2014-2025
Figure Dabrafenib Figures
Table Major Manufacturers of Dabrafenib
Figure Sorafenib Figures
Table Major Manufacturers of Sorafenib
Figure Vemurafenib Figures
Table Major Manufacturers of Vemurafenib
Figure Encorafenib Figures
Table Major Manufacturers of Encorafenib
Table Global BRAF Kinase Inhibitors Market Share by Application 2019-2025 (K Liter)
Figure Hospital Use Case
Figure Medical Research Institute Use Case
Figure Clinic Use Case
Figure Other Use Case
Figure BRAF Kinase Inhibitors Report Years Considered
Figure Global BRAF Kinase Inhibitors Market Size 2014-2025 (Million US$)
Figure Global BRAF Kinase Inhibitors Sales 2014-2019 (K Liter)
Table Global BRAF Kinase Inhibitors Market Size by Regions 2014-2019 (K Liter) & (Million US$)
Table Global BRAF Kinase Inhibitors Sales by Regions 2014-2019 (K Liter)
Table Global BRAF Kinase Inhibitors Sales Market Share by Regions 2014-2019
Figure Global BRAF Kinase Inhibitors Sales Market Share by Regions 2014-2019
Figure Global BRAF Kinase Inhibitors Sales Market Share by Regions in 2018
Table Global BRAF Kinase Inhibitors Revenue by Regions 2014-2019 (Million US$)
Table Global BRAF Kinase Inhibitors Revenue Market Share by Regions 2014-2019
Figure Global BRAF Kinase Inhibitors Revenue Market Share by Regions 2014-2019
Figure Global BRAF Kinase Inhibitors Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global BRAF Kinase Inhibitors Sales by Manufacturers (2014-2019) (K Liter)
Table Global BRAF Kinase Inhibitors Sales Share by Manufacturers (2014-2019)
Figure Global BRAF Kinase Inhibitors Sales Share by Manufacturers in 2018
Table BRAF Kinase Inhibitors Revenue by Manufacturers (2014-2019) (Million USD)
Table BRAF Kinase Inhibitors Revenue Share by Manufacturers (2014-2019)
Figure BRAF Kinase Inhibitors Value Share by Manufacturers in 2018
Table Global BRAF Kinase Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers BRAF Kinase Inhibitors Price (2014-2019) (USD/Liter)
Table Key Manufacturers BRAF Kinase Inhibitors Plants/Factories Distribution
Table Key Manufacturers BRAF Kinase Inhibitors Area Served
Table Date of Key Manufacturers Enter into BRAF Kinase Inhibitors Market
Table Key Manufacturers BRAF Kinase Inhibitors Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Dabrafenib Sales an目录输出!D Revenue (2014-2019) (K Liter) & (Million US$)
Table Global Sorafenib Sales an目录输出!D Revenue (2014-2019) (K Liter) & (Million US$)
Table Global Vemurafenib Sales an目录输出!D Revenue (2014-2019) (K Liter) & (Million US$)
Table Global Encorafenib Sales an目录输出!D Revenue (2014-2019) (K Liter) & (Million US$)
Table Global BRAF Kinase Inhibitors Sales by Type (2014-2019) (K Liter)
Table Global BRAF Kinase Inhibitors Sales Share by Type (2014-2019)
Figure Global BRAF Kinase Inhibitors Sales Market Share by Type (2014-2019)
Figure Global BRAF Kinase Inhibitors Sales Market Share by Type in 2018
Table Global BRAF Kinase Inhibitors Revenue by Type (2014-2019) (Million US$)
Table Global BRAF Kinase Inhibitors Revenue Share by Type (2014-2019)
Figure Global BRAF Kinase Inhibitors Revenue Market Share by Type (2014-2019)
Figure Global BRAF Kinase Inhibitors Revenue Market Share by Type in 2018
Table BRAF Kinase Inhibitors Price by Type 2014-2019 (USD/Liter)
Table Global BRAF Kinase Inhibitors Sales by Application (2014-2019) (K Liter)
Table Global BRAF Kinase Inhibitors Sales Share by Application (2014-2019)
Figure Global Sales BRAF Kinase Inhibitors Market Share by Application (2014-2019)
Figure Global Sales BRAF Kinase Inhibitors Market Share by Application in 2018
Figure North America BRAF Kinase Inhibitors Sales Growth Rate 2014-2019 (K Liter)
Figure North America BRAF Kinase Inhibitors Revenue Growth Rate 2014-2019 (Million US$)
Table North America BRAF Kinase Inhibitors Sales by Company (2014-2019) (K Liter)
Table North America BRAF Kinase Inhibitors Sales Market Share by Company (2014-2019)
Figure North America BRAF Kinase Inhibitors Sales Market Share by Company in 2018
Table North America BRAF Kinase Inhibitors Sales by Type (2014-2019) (K Liter)
Table North America BRAF Kinase Inhibitors Sales Market Share by Type (2014-2019)
Figure North America BRAF Kinase Inhibitors Market Share by Type in 2018
Table North America BRAF Kinase Inhibitors Sales by Application (2014-2019) (K Liter)
Table North America BRAF Kinase Inhibitors Sales Market Share by Application (2014-2019)
Figure North America BRAF Kinase Inhibitors Market Share by Application in 2018
Table North America BRAF Kinase Inhibitors Sales by Countries (2014-2019) (K Liter)
Table North America BRAF Kinase Inhibitors Sales Market Share by Countries (2014-2019)
Figure North America BRAF Kinase Inhibitors Sales Market Share by Countries in 2018
Table North America BRAF Kinase Inhibitors Revenue by Countries (2014-2019) (Million US$)
Table North America BRAF Kinase Inhibitors Revenue Market Share by Countries (2014-2019)
Figure North America BRAF Kinase Inhibitors Revenue Market Share by Countries in 2018
Figure United States BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Canada BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Mexico BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Europe BRAF Kinase Inhibitors Sales Growth Rate 2014-2019 (K Liter)
Figure Europe BRAF Kinase Inhibitors Revenue Growth Rate 2014-2019 (Million US$)
Table Europe BRAF Kinase Inhibitors Sales by Company (2014-2019) (K Liter)
Table Europe BRAF Kinase Inhibitors Sales Market Share by Company (2014-2019)
Figure Europe BRAF Kinase Inhibitors Sales Market Share by Company in 2018
Table Europe BRAF Kinase Inhibitors Sales by Type (2014-2019) (K Liter)
Table Europe BRAF Kinase Inhibitors Sales Market Share by Type (2014-2019)
Figure Europe BRAF Kinase Inhibitors Sales Market Share by Type in 2018
Table Europe BRAF Kinase Inhibitors Sales by Application (2014-2019) (K Liter)
Table Europe BRAF Kinase Inhibitors Sales Market Share by Application (2014-2019)
Figure Europe BRAF Kinase Inhibitors Sales Market Share by Application in 2018
Table Europe BRAF Kinase Inhibitors Sales by Countries (2014-2019) (K Liter)
Table Europe BRAF Kinase Inhibitors Sales Market Share by Countries (2014-2019)
Figure Europe BRAF Kinase Inhibitors Sales Market Share by Countries in 2018
Table Europe BRAF Kinase Inhibitors Revenue by Countries (2014-2019) (Million US$)
Table Europe BRAF Kinase Inhibitors Revenue Market Share by Countries (2014-2019)
Figure Europe BRAF Kinase Inhibitors Revenue Market Share by Countries in 2018
Figure Germany BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure France BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure UK BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Italy BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Russia BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Asia Pacific BRAF Kinase Inhibitors Sales Growth Rate 2014-2019 (K Liter)
Figure Asia Pacific BRAF Kinase Inhibitors Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific BRAF Kinase Inhibitors Sales by Regions (2014-2019) (K Liter)
Table Asia Pacific BRAF Kinase Inhibitors Sales Market Share by Regions (2014-2019)
Figure Asia Pacific BRAF Kinase Inhibitors Sales Market Share by Regions in 2018
Table Asia Pacific BRAF Kinase Inhibitors Sales by Type (2014-2019) (K Liter)
Table Asia Pacific BRAF Kinase Inhibitors Sales Market Share by Type (2014-2019)
Figure Asia Pacific BRAF Kinase Inhibitors Market Share by Type in 2018
Table Asia Pacific BRAF Kinase Inhibitors Sales by Application (2014-2019) (K Liter)
Table Asia Pacific BRAF Kinase Inhibitors Sales Market Share by Application (2014-2019)
Figure Asia Pacific BRAF Kinase Inhibitors Market Share by Application in 2018
Table Asia Pacific BRAF Kinase Inhibitors Sales by Countries (2014-2019) (K Liter)
Table Asia Pacific BRAF Kinase Inhibitors Sales Market Share by Regions (2014-2019)
Figure Asia Pacific BRAF Kinase Inhibitors Sales Market Share by Regions in 2018
Table Asia Pacific BRAF Kinase Inhibitors Revenue by Regions (2014-2019) (Million US$)
Table Asia Pacific BRAF Kinase Inhibitors Revenue Market Share by Regions (2014-2019)
Figure Asia Pacific BRAF Kinase Inhibitors Revenue Market Share by Regions in 2018
Figure China BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure China BRAF Kinase Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Japan BRAF Kinase Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Korea BRAF Kinase Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure India BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure India BRAF Kinase Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Australia BRAF Kinase Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Indonesia BRAF Kinase Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Malaysia BRAF Kinase Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Philippines BRAF Kinase Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Thailand BRAF Kinase Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Vietnam BRAF Kinase Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Central & South America BRAF Kinase Inhibitors Sales Growth Rate 2014-2019 (K Liter)
Figure Central & South America BRAF Kinase Inhibitors Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America BRAF Kinase Inhibitors Sales by Company (2014-2019) (K Liter)
Table Central & South America BRAF Kinase Inhibitors Sales Market Share by Company (2014-2019)
Figure Central & South America BRAF Kinase Inhibitors Sales Market Share by Company in 2018
Table Central & South America BRAF Kinase Inhibitors Sales by Type (2014-2019) (K Liter)
Table Central & South America BRAF Kinase Inhibitors Sales Market Share by Type (2014-2019)
Figure Central & South America BRAF Kinase Inhibitors Market Share by Type in 2018
Table Central & South America BRAF Kinase Inhibitors Sales by Application (2014-2019) (K Liter)
Table Central & South America BRAF Kinase Inhibitors Sales Market Share by Application (2014-2019)
Figure Central & South America BRAF Kinase Inhibitors Market Share by Application in 2018
Table Central & South America BRAF Kinase Inhibitors Sales by Countries (2014-2019) (K Liter)
Table Central & South America BRAF Kinase Inhibitors Sales Market Share by Countries (2014-2019)
Figure Central & South America BRAF Kinase Inhibitors Sales Market Share by Countries in 2018
Table Central & South America BRAF Kinase Inhibitors Revenue by Countries (2014-2019) (Million US$)
Table Central & South America BRAF Kinase Inhibitors Revenue Market Share by Countries (2014-2019)
Figure Central & South America BRAF Kinase Inhibitors Revenue Market Share by Countries in 2018
Figure Brazil BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Brazil BRAF Kinase Inhibitors Revenue Growth Rate (2014-2019) (K Liter)
Figure Middle East and Africa BRAF Kinase Inhibitors Sales Growth Rate 2014-2019 (K Liter)
Figure Middle East and Africa BRAF Kinase Inhibitors Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa BRAF Kinase Inhibitors Sales by Type (2014-2019) (K Liter)
Table Middle East and Africa BRAF Kinase Inhibitors Sales Market Share by Type (2014-2019)
Figure Middle East and Africa BRAF Kinase Inhibitors Sales Market Share by Type in 2018
Table Middle East and Africa BRAF Kinase Inhibitors Sales by Application (2014-2019) (K Liter)
Table Middle East and Africa BRAF Kinase Inhibitors Sales Market Share by Application (2014-2019)
Figure Middle East and Africa BRAF Kinase Inhibitors Sales Market Share by Application in 2018
Table Middle East and Africa BRAF Kinase Inhibitors Sales by Countries (2014-2019) (K Liter)
Table Middle East and Africa BRAF Kinase Inhibitors Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa BRAF Kinase Inhibitors Sales Market Share by Countries in 2018
Table Middle East and Africa BRAF Kinase Inhibitors Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa BRAF Kinase Inhibitors Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa BRAF Kinase Inhibitors Revenue Market Share by Countries in 2018
Figure GCC Countries BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure GCC Countries BRAF Kinase Inhibitors Revenue Growth Rate (2014-2019) (K Liter)
Figure Egypt BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Egypt BRAF Kinase Inhibitors Revenue Growth Rate (2014-2019) (K Liter)
Figure South Africa BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure South Africa BRAF Kinase Inhibitors Revenue Growth Rate (2014-2019) (K Liter)
Table Array BioPharma Inc. Company Details
Table Array BioPharma Inc. Description and Business Overview
Table Array BioPharma Inc. BRAF Kinase Inhibitors Sales (K Liter), Revenue (Million US$), Price (USD/Liter) and Gross Margin (2014-2019)
Table Array BioPharma Inc. BRAF Kinase Inhibitors Sales Growth Rate (2014-2019)
Table Array BioPharma Inc. BRAF Kinase Inhibitors Sales Market Share in Global Market
Table Array BioPharma Inc. Recent Development
Table Bayer AG Company Details
Table Bayer AG Description and Business Overview
Table Bayer AG BRAF Kinase Inhibitors Sales (K Liter), Revenue (Million US$), Price (USD/Liter) and Gross Margin (2014-2019)
Table Bayer AG BRAF Kinase Inhibitors Sales Growth Rate (2014-2019)
Table Bayer AG BRAF Kinase Inhibitors Sales Market Share in Global Market
Table Bayer AG Recent Development
Table F. Hoffmann-La Roche Ltd. Company Details
Table F. Hoffmann-La Roche Ltd. Description and Business Overview
Table F. Hoffmann-La Roche Ltd. BRAF Kinase Inhibitors Sales (K Liter), Revenue (Million US$), Price (USD/Liter) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Ltd. BRAF Kinase Inhibitors Sales Growth Rate (2014-2019)
Table F. Hoffmann-La Roche Ltd. BRAF Kinase Inhibitors Sales Market Share in Global Market
Table F. Hoffmann-La Roche Ltd. Recent Development
Table Novartis AG Company Details
Table Novartis AG Description and Business Overview
Table Novartis AG BRAF Kinase Inhibitors Sales (K Liter), Revenue (Million US$), Price (USD/Liter) and Gross Margin (2014-2019)
Table Novartis AG BRAF Kinase Inhibitors Sales Growth Rate (2014-2019)
Table Novartis AG BRAF Kinase Inhibitors Sales Market Share in Global Market
Table Novartis AG Recent Development
Figure BRAF Kinase Inhibitors Value Chain
Table BRAF Kinase Inhibitors Distributors List
Table BRAF Kinase Inhibitors Customers List
Table Global BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter) & (Million US$)
Figure Global BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Global BRAF Kinase Inhibitors Revenue Forecast 2019-2025 (Million US$)
Table Global BRAF Kinase Inhibitors Sales Forecast by Type 2019-2025 (K Liter)
Figure Global BRAF Kinase Inhibitors Sales Forecast by Type 2019-2025 (K Liter)
Figure Global BRAF Kinase Inhibitors Sales Market Share Forecast by Type 2019-2025
Table Global BRAF Kinase Inhibitors Sales Forecast by Application 2019-2025 (K Liter)
Figure Global BRAF Kinase Inhibitors Sales Forecast by Application 2019-2025 (K Liter)
Figure Global BRAF Kinase Inhibitors Sales Market Share Forecast by Application 2019-2025
Table Global BRAF Kinase Inhibitors Sales Forecast by Regions 2019-2025 (K Liter)
Figure Global BRAF Kinase Inhibitors Sales Forecast by Regions 2019-2025 (K Liter)
Figure Global BRAF Kinase Inhibitors Sales Market Share Forecast by Regions 2019-2025
Table Global BRAF Kinase Inhibitors Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global BRAF Kinase Inhibitors Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global BRAF Kinase Inhibitors Revenue Market Share Forecast by Regions 2019-2025
Table North America BRAF Kinase Inhibitors Sales Forecast by Countries 2019-2025 (K Liter)
Table North America BRAF Kinase Inhibitors Sales Market Share Forecast by Countries 2019-2025
Table North America BRAF Kinase Inhibitors Revenue Forecast by Countries 2019-2025 (Million US$)
Table North America BRAF Kinase Inhibitors Revenue Market Share Forecast by Countries 2019-2025
Figure United States BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Canada BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Mexico BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Table Europe BRAF Kinase Inhibitors Sales Forecast by Countries 2019-2025 (K Liter)
Table Europe BRAF Kinase Inhibitors Sales Market Share Forecast by Countries 2019-2025
Table Europe BRAF Kinase Inhibitors Revenue Forecast by Countries 2019-2025 (Million US$)
Table Europe BRAF Kinase Inhibitors Revenue Market Share Forecast by Countries 2019-2025
Figure Germany BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure France BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure UK BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Italy BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Russia BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Table Asia Pacific BRAF Kinase Inhibitors Sales Forecast by Regions 2019-2025 (K Liter)
Table Asia Pacific BRAF Kinase Inhibitors Sales Market Share Forecast by Regions 2019-2025
Table Asia Pacific BRAF Kinase Inhibitors Revenue Forecast by Regions 2019-2025 (Million US$)
Table Asia Pacific BRAF Kinase Inhibitors Revenue Market Share Forecast by Regions 2019-2025
Figure China BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Japan BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure South Korea BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure India BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Australia BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Indonesia BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Thailand BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Malaysia BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Philippines BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Vietnam BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Table Central & South America BRAF Kinase Inhibitors Sales Forecast by Countries 2019-2025 (K Liter)
Table Central & South America BRAF Kinase Inhibitors Sales Market Share Forecast by Countries 2019-2025
Table Central & South America BRAF Kinase Inhibitors Revenue Forecast by Countries 2019-2025 (Million US$)
Table Central & South America BRAF Kinase Inhibitors Revenue Market Share Forecast by Countries 2019-2025
Figure Brazil BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Table Middle East and Africa BRAF Kinase Inhibitors Sales Forecast by Regions 2019-2025 (K Liter)
Table Middle East and Africa BRAF Kinase Inhibitors Sales Market Share Forecast by Regions 2019-2025
Table Middle East and Africa BRAF Kinase Inhibitors Revenue Forecast by Regions 2019-2025 (Million US$)
Table Middle East and Africa BRAF Kinase Inhibitors Revenue Market Share Forecast by Regions 2019-2025
Figure Turkey BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure GCC Countries BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Egypt BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure South Africa BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

世界のヤヌスキナーゼ（JAK）阻害剤産業調査2019-2025

Global Janus Kinase (JAK) Inhibitors Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
QYR9NV16247 2019年11月16日 117Pages
※本調査レポートでは、世界のヤヌスキナーゼ（JAK）阻害剤市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。ヤヌスキナーゼ（JAK）阻害剤の種類別には、自己免疫疾患、腫瘍学に、用途別には、クリニック、病院に、地域別...

非チロシンキナーゼ阻害剤のグローバル市場調査 2019年

Global Non-Tyrosine Kinase Inhibitors Market Professional Survey Report 2019
QYR9NV09033 2019年11月14日 112Pages
※本調査レポートは、非チロシンキナーゼ阻害剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、mTOR阻害剤、RAF / MEK阻害剤、CDK阻害剤に、用途別に...

世界のMEK阻害剤産業調査2019-2025

Global MEK Inhibitors Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
QYR9NV16443 2019年11月16日 118Pages
※本調査レポートでは、世界のMEK阻害剤市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。MEK阻害剤の種類別には、メキニスト、コテリック、メクトビに、用途別には、NSCLC、がんに、地域別には、北米、アメリカ、ヨ...

世界のホスホジエステラーゼ（PDE）阻害剤産業調査2019-2025

Global Phosphodiesterase (PDE) inhibitors Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
QYR9NV16723 2019年11月18日 118Pages
※本調査レポートでは、世界のホスホジエステラーゼ（PDE）阻害剤市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。ホスホジエステラーゼ（PDE）阻害剤の種類別には、PDE1選択的阻害剤、PDE2選択的阻害剤、PDE...

BCL-2（B細胞リンパ腫2）阻害剤のグローバル市場：規模・現状・予測2019-2025

Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, Status and Forecast 2019-2025
QYR9NV17679 2019年11月18日 93Pages
※当調査レポートでは、BCL-2（B細胞リンパ腫2）阻害剤の世界市場について調査・分析し、BCL-2（B細胞リンパ腫2）阻害剤の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（併用療法、単剤療法）、用...

B細胞リンパ腫2阻害剤のグローバル市場：規模・現状・予測2019-2025

Global B-cell lymphoma 2 Inhibitors Market Size, Status and Forecast 2019-2025
QYR9NV17678 2019年11月18日 95Pages
※当調査レポートでは、B細胞リンパ腫2阻害剤の世界市場について調査・分析し、B細胞リンパ腫2阻害剤の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（併用療法、単剤療法）、用途別（慢性リンパ性白血病、小...

選択的セロトニン再取り込み阻害薬（SSRI）のグローバル市場：規模・現状・予測2019-2025

Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size, Status and Forecast 2019-2025
QYR9NV18407 2019年11月18日 99Pages
※当調査レポートでは、選択的セロトニン再取り込み阻害薬（SSRI）の世界市場について調査・分析し、選択的セロトニン再取り込み阻害薬（SSRI）の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（シタロプ...

PARP（ポリADPリボースポリメラーゼ）阻害剤のグローバル市場：規模・現状・予測2019-2025

Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size, Status and Forecast 2019-2025
QYR9NV18254 2019年11月18日 92Pages
※当調査レポートでは、PARP（ポリADPリボースポリメラーゼ）阻害剤の世界市場について調査・分析し、PARP（ポリADPリボースポリメラーゼ）阻害剤の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（...

血管内皮増殖因子(VEGF)阻害剤のグローバル市場：規模・現状・予測2019-2025

Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size, Status and Forecast 2019-2025
QYR9NV18526 2019年11月18日 91Pages
※当調査レポートでは、血管内皮増殖因子(VEGF)阻害剤の世界市場について調査・分析し、血管内皮増殖因子(VEGF)阻害剤の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（VEGF-A阻害剤、VEGF...

ベータラクタムおよびベータラクタマーゼ阻害剤のグローバル市場：規模・現状・予測2019-2025

Global Beta-lactam and Beta-lactamase Inhibitors Market Size, Status and Forecast 2019-2025
QYR9NV17687 2019年11月18日 97Pages
※当調査レポートでは、ベータラクタムおよびベータラクタマーゼ阻害剤の世界市場について調査・分析し、ベータラクタムおよびベータラクタマーゼ阻害剤の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ペニシリ...

世界のヤヌスキナーゼ（JAK）阻害剤産業調査2019-2025 Janus kinase inhibitors are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway.In 2018, the global Janus Kinase (JAK) Inhibitors market size was xx milli…
非チロシンキナーゼ阻害剤のグローバル市場調査 2019年 The global Non-Tyrosine Kinase Inhibitors market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Non-Tyrosine Kinase Inhibitors volume and value at global level, regional level and company level. From a gl…
プロテインキナーゼ阻害剤のグローバル市場調査 2019年 The global Protein Kinase Inhibitor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Protein Kinase Inhibitor volume and value at global level, regional level and company level. From a global perspec…
MAPキナーゼ相互作用セリンプロテインキナーゼ1のグローバル市場調査 2019年 The global MAP Kinase Interacting Serine Protein Kinase 1 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on MAP Kinase Interacting Serine Protein Kinase 1 volume and value at global level, regional le…
プロテインキナーゼCイプシロンタイプのグローバル市場調査 2019年 The global Protein Kinase C Epsilon Type market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Protein Kinase C Epsilon Type volume and value at global level, regional level and company level. From a glob…